PubMed HealthSearch

Biomedical subjects

J E Simpson

Publications and source records attributed to J E Simpson.

13 recordsLinked to original sources

Hypertrophic scarring: Dexon suture in a randomized trial.

In a randomized prospective trial of three methods of skin suture an increased incidence of hypertrophic scarring in paramedian and inguinal wounds has been found to be associated with the use of 2/0 Dexon suture subcuticularly. However, the variance associated with the type of suture was less than that associated with the sex of the patient. The patient's opinion of the appearance of the scar was the same for all three suture methods used in skin closure.

Abdomen

Them and us.

Explore the source record for details and available documents.

Allied Health Personnel

Relative efficacy of two oxytetracycline formulations and doxycycline in the treatment of acute anaplasmosis in splenectomized calves.

The efficacy of 3 antibiotic formulations was measured in the treatment of artificially induced anaplasmosis in the early stages of an ascending parasitemia (1% to 4%) in 23 splenectomized calves. Group 1, consisting of 5 calves, served as nontreated controls. Four calves (group 2) were treated 1 time with 10 mg of oxytetracycline (T-50)/kg of body weight IM; 5 calves (group 3) were treated 3 times with 10 mg of T-50/kg IM; 5 calves (group 4) were treated 1 time with 20 mg of an experimental oxytetracycline (T-200)/kg IM; and 4 calves (group 5) were treated 1 time with 10 mg of a synthetically derived antibacterial agent, doxycycline (D-100)/kg IM. All control calves died and 1 of 4 calves died that was treated 1 time with T-50. Other deaths did not occur. All treatments were effective in moderating the infective process, but T-50 given 3 times and T-200 given 1 time were markedly more effective than T-50 and D-100 given 1 time. There appeared to be little or no difference in therapeutic efficacy between T-50 and D-100 given 1 time and between T-50 given 3 times and T-200 given 1 time.

Acute Disease

Elimination of the carrier state of bovine anaplasmosis with a long-acting oxytetracycline.

A long-acting formulation of oxytetracycline (L-200) was injected at a dose level of 20 mg/kg intramuscularly into 12 yearling cattle that had been experimentally inoculated with Anaplasma marginale 64 days previously. Four cattle were treated twice, 4 were treated 3 times, and 4 were treated 4 times. All injections were given once ever 7 days. Previous work (unpublished) with this formulation has revealed prolonged blood values following a single injection. The blood (80 ml) of each calf was inoculated into a susceptible test calf 83 days after the last treatment dose. Anaplasmosis did not occur in any of the test calves. Two infected cattle were treated with 12 daily injections of oxytetracycline (L-50) at a dose level of 11 mg/kg to establish the sensitivity of the parasite to oxytetracycline. Subsequent calf inoculation tests showed that A marginale was eliminated. Two unmedicated, infected cattle remained infected throughout the study. Complement-fixation tests with A marginale antigen at 6 months after treatment showed average sera titers of less than 5 in the treated cattle and 45 in the unmedicated cattle.

Anaplasmosis

Efficacy of a new oxytetracycline formulation against clinical anaplasmosis.

A study was conducted to determine whether 1 intramuscular injection of an experimental long-acting oxytetracycline formulation was effective in treatment of induced acute anaplasmosis in cattle and to compare this with the drug response resulting from repeated treatments with an existing, approved oxytetracycline product. The new formulation was supplied in solutions of 200 mg of oxytetracycline/ml and was administered 1 time at the rate of 20 mg/kg of body weight. The experimental formulation was compared with a product providing 50 mg of oxytetracycline/ml which was administered on 2 consecutive days at the dose rate of 10 mg/kg for each treatment. The response to treatment observed in the study animals indicates that 1 injection of the experimental formulation was equivalent to 2 daily injections of the 50 mg/ml product in treating animals with acute bovine anaplasmosis compared with infected nonmedicated control animals. The need for new chemotherapeutic compounds such as this formulation for use in the treatment and control of anaplasmosis is discussed.

Anaplasmosis

"Right" stay in hospital after sugery: randomised controlled trial.

A randomised controlled trial was carried out on 100 patients to compare the effects of discharge after certain pre-specified clinical criteria had been fulfilled--"right" stay--with those of discharge at an arbitrary 10 days after surgery--"fixed" stay. The operations concerned (cholecystectomy and vagotomy) were more hazardous than those previously included in studies of early discharge. Patients in the right-stay group were discharged, on average, 7-6 days after operation--that is, two days earlier than those in the fixed-stay group. In terms of clinical progress, social factors such as return to work, and the acceptability to patients and relatives of the implications of right stay, patients in this group fared as well as those in the fixed-stay group, and in some respects slightly better. Right stay entailed the transfer of some work from hospital to community medical and nursing staff, but this also was acceptable. The concept and use of the right-stay principle is of value in planning the postoperative discharge of suitable patients.

Adult

Length of stay.

Explore the source record for details and available documents.

Convalescence

Comparative study of short-term recovery of mental efficiency after anaesthesia.

Two common general anaesthetic techniques were compared to evaluate the time taken for the patient's mental efficiency to recover sufficiently for him to be escorted home after inguinal herniorrhaphy. Recovery in performance efficiency to at least 60% of the patient's own maximum is suggested as a criterion for discharge, and this needs a stay in hospital of seven to nine hours.

Anesthesia, General

Faecal bile-acids and clostridia in patients with cancer of the large bowel.

Of 44 patients with cancer of the large bowel, 36 ( 82%) had high faecal bile-acid concentrations compared with only 15 (17%) out of 90 patients with other diseases. 31 (70%) of the 44 patients with large-bowel cancer had high faecal bile-acid concentrations in the presence of faecal clostridia able to dehydrogenate the bile-acid nucleus, compared with only 8 (9%) out of 90 patients with other diseases. Thes findings support the hypothesis that cancer of the large bowel is caused by high concentrations of bile-acid derivatives produced by certain anaerobic bacteria.

Adult

Glycolytic enzymes in resting spores and vegetative mycelia of Entomophthora pyriformis.

Specific activities of 14 enzymes of the Embden-Meyerhof-Parnas and pentose phosphate pathways were determined in extracts of resting spores and vegetative mycelia of Entomophthora pyriformis. All these enzymes were detected in mycelial extracts, whereas only nine were detectable in resting spore extracts. Activities of detectable spore enzymes were much lower than those of the corresponding mycelial enzymes with the exception of triosephosphate dehydrogenase, which had higher activity in spore extracts. The enzyme deficiencies noted point to the inability of either pathway to function in dormant spores.

Carbohydrate Epimerases